Plasminogen Activator Inhibitor-1 Suppresses Profibrotic Responses in Fibroblasts from Fibrotic Lungs
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Background: The long term survival outcome of patients with IPF is bleak, with a paucity of effective treatments. Results: The changes in baseline PAI-1 expression regulate fibroblast activation and expansion in fibrotic lung diseases. Conclusion: Targeted restoration, rather than inhibition of PAI-1 in activated fibroblasts, mitigates fibrosis. Significance: This study defines a new role of PAI-1 in the pathogenesis of fibrosing lung diseases, including IPF. Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease characterized by progressive interstitial scarification. A hallmark morphological lesion is the accumulation of myofibroblasts or fibrotic lung fibroblasts (FL-fibroblasts) in areas called fibroblastic foci. We previously demonstrated that the expression of both urokinase-type plasminogen activator (uPA) and the uPA receptor are elevated in FL-fibroblasts from the lungs of patients with IPF. FL-fibroblasts isolated from human IPF lungs and from mice with bleomycin-induced pulmonary fibrosis showed an increased rate of proliferation compared with normal lung fibroblasts (NL-fibroblasts) derived from histologically "normal" lung. Basal expression of plasminogen activator inhibitor-1 (PAI-1) in human and murine FL-fibroblasts was reduced, whereas collagen-I and α-smooth muscle actin were markedly elevated. Conversely, alveolar type II epithelial cells surrounding the fibrotic foci in situ , as well as those isolated from IPF lungs, showed increased activation of caspase-3 and PAI-1 with a parallel reduction in uPA expression. Transduction of an adenovirus PAI-1 cDNA construct (Ad-PAI-1) suppressed expression of uPA and collagen-I and attenuated proliferation in FL-fibroblasts. On the contrary, inhibition of basal PAI-1 in NL-fibroblasts increased collagen-I and α-smooth muscle actin. Fibroblasts isolated from PAI-1-deficient mice without lung injury also showed increased collagen-I and uPA. These changes were associated with increased Akt/phosphatase and tensin homolog proliferation/survival signals in FL-fibroblasts, which were reversed by transduction with Ad-PAI-1. This study defines a new role of PAI-1 in the control of fibroblast activation and expansion and its role in the pathogenesis of fibrosing lung disease and, in particular, IPF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TGF-β signaling and the fibrotic response
Leask, A., & Abraham, D. J. (2004) · The FASEB Journal · doi:10.1096/fj.03-1273rev · Cited by 2,319 · cited 1×
“Excessive FL-fibroblast activation, proliferation (22), migration (7, 8), release of pro-fibrotic cytokines (39), and resistance to apoptosis (40) all appear to contribute to the massive deposition of ECM and architectural distortion that occurs in IPF.”
BackgroundThe RB and p53 pathways in cancer
Sherr, C. J., & McCormick, F. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00102-2 · Cited by 1,690 · cited 1×
“Our observations are further supported by the fact that the PI3K/Akt/GSK3 pathway regulates cyclin D1 kinase, which promotes cell proliferation (58).”
BackgroundKortlever, R. M., Higgins, P. J., & Bernards, R. (2006) · Nature Cell Biology · doi:10.1038/ncb1448 · Cited by 637 · cited 6×
“PAI-1 inhibits Akt phosphorylation in multiple cell types, including lung fibroblasts (16, 38).”
BackgroundInfluentialCaveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis
Wang, X. M., Zhang, Y., Kim, H. P., Zhou, Z., Feghali-Bostwick, C. A., Liu, F., Ifedigbo, E., Xu, X., Oury, T. D., Kaminski, N., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061536 · Cited by 397 · cited 1×
“Forced expression of caveolin-1 expression in FL-fibroblasts or in mice with BLM-induced lung injury mitigates pulmonary fibrosis (72).”
BackgroundElzi, D. J., Lai, Y., Song, M., Hakala, K., Weintraub, S. T., & Shiio, Y. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120437109 · Cited by 154
Pechkovsky, D. V., Prêle, C. M., Wong, J., Hogaboam, C. M., McAnulty, R. J., Laurent, G. J., Zhang, S. S.-M., Selman, M., Mutsaers, S. E., & Knight, D. A. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.12.022 · Cited by 127
Cited by
Jiang, C., Liu, G., Luckhardt, T., Antony, V., Zhou, Y., Carter, A. B., Thannickal, V. J., & Liu, R. (2017) · Aging Cell · doi:10.1111/acel.12643 · Cited by 234
Inhibition of NF-κB by ACT001 reduces fibroblast activity in idiopathic pulmonary fibrosis
Jaffar, J., Glaspole, I., Symons, K., & Westall, G. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111471 · Cited by 45
p53 Expression in Lung Fibroblasts Is Linked to Mitigation of Fibrotic Lung Remodeling
Nagaraja, M. R., Tiwari, N., Shetty, S. K., Marudamuthu, A. S., Fan, L., Ostrom, R. S., Fu, J., Gopu, V., Radhakrishnan, V., Idell, S., et al. (2018) · The American Journal of Pathology · doi:10.1016/j.ajpath.2018.07.005 · Cited by 37
Self-citationFan, L., Shetty, R. S., Dao, H. M., Balnadupete, A., Somasundram, B., Bhagavath, A. K., Kongara, A., Tang, H., Citrin, D. E., Williams, R. O., et al. (2025) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00295.2024 · Cited by 3
Self-citation
Metadata
- Authors
- Marudamuthu, A. S., Shetty, S. K., Bhandary, Y. P., Karandashova, S., Thompson, M., Sathish, V., Florova, G., Hogan, T. B., Pabelick, C. M., Prakash, Y. S., Tsukasaki, Y., Fu, J., Ikebe, M., Idell, S., & Shetty, S.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2015-04
- Volume
- 290
- Issue
- 15
- Pages
- 9428-9441
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1964123603
- Cited by
- 50
- References
- 6
- FWCI
- 4.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Plasminogen Activator Inhibitor-1 Suppresses Profibrotic Responses in Fibroblasts from Fibrotic Lungs. https://app.cochat.ai/papers/10.1074/jbc.m114.601815
- The paper
- Marudamuthu, A. S., Shetty, S. K., Bhandary, Y. P., Karandashova, S., Thompson, M., Sathish, V., Florova, G., Hogan, T. B., Pabelick, C. M., Prakash, Y. S., Tsukasaki, Y., Fu, J., Ikebe, M., Idell, S., & Shetty, S. (2015). Plasminogen Activator Inhibitor-1 Suppresses Profibrotic Responses in Fibroblasts from Fibrotic Lungs. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.m114.601815
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.